CheckCap (CHEK)
(Delayed Data from NSDQ)
$1.73 USD
0.00 (0.00%)
Updated Sep 19, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Check-Cap Ltd. [CHEK]
Reports for Purchase
Showing records 1 - 20 ( 79 total )
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap: Shareholders Vote No to Merger with Keystone Dental - Too Much Dilution
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap: 5.6% Holder Symetryx Issues Open Letter - Vote No! For the Keystone Dental Holdings Merger - Too Much Dilution
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap: Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Business Combination Agreement Inked; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Calibration Studies Discontinued and Workforce Reduced; Downgrading to Neutral Without PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap: Strategic Alternatives - $37M in Cash Remains
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap- Reports Full Year 2022. The Company Has Cash but?
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
U.S. Pivotal Trial Timeline Delayed; 2022 Results; Reiterate Buy; Lowering PT to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap - CV Scan Update - Delays, Delays & Delays
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap - Reports 3rd Quarter and Effects a 1 for 10 Reverse Stock Split, We Remain Neutral
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
3Q22 Financial Results; Reverse Stock Split Effected; Reiterate Buy; Instituting $15 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap Reports 2Q22 ~ $50M in Cash on Balance Sheet Reverse Split is Coming Lowering to Neutral
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap Reports 1Q22 ~ $56M in Cash on Balance Sheet
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
U.S. Pivotal Trial of C-Scan Initiated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Company: Check-Cap Ltd.
Industry: Medical - Instruments
Check-Cap Reports 4Q21 - $52M in Cash on Balance Sheet
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J